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Background: Cilostazol, a phosphodiesterase3 (PDE3) inhibitor, increases the intracellular cyclic 
adenosine monophosphate (cAMP) level in vascular smooth muscle cells causing vasodilation and 
is widely used for the supportive treatment of chronic peripheral vascular diseases. Topical 
application of cilostazol is reported to improve local blood flow in rabbit skin and enhance wound 
healing.
Objective: Herein, we introduce the promotive effect of cilostazol on hair growth for the first time.
Methods: To validate the effects of cilostazol on hair growth, we treated cilostazol to human dermal 
papilla (DP) cells and to outer root sheath (ORS) cells, and performed ex vivo hair follicle organ 
culture. Also, we demonstrated the effect of cilostazol on C57BL/6 mice model.
Results: As a result, we confirmed that the mRNA levels of PDE3A and PDE3B were highly 
expressed in human DP cells, but almost absent in ORS cells. Cilostazol significantly enhanced the 
viability of DP cells and increased phosphorylated extracellular signal-regulated kinase (ERK) levels 
proven by western blot analysis. Additionally, cilostazol promoted hair shaft elongation with 
increased proliferation of matrix keratinocytes in hair follicle organ culture. Furthermore, cilostazol 
treatment accelerated the anagen hair induction when topically applied on 7-week-old C57BL/6 
mice.
Conclusion: Our results show that cilostazol promoted hair growth and may serve as an alternative 
therapeutic target for the treatment of alopecia.
